Elephant's Foot — Benefits Deep Dive
Elephant's Foot (Elephantopus scaber) is a pantropical roadside weed used across Vietnamese, Chinese, Indonesian, Thai, Indian and Brazilian traditional medicine for fever, liver complaints, wounds, and — in a laboratory literature that has grown substantially in the last fifteen years — as a source of a genuinely potent anticancer compound, deoxyelephantopin. Nearly everything on the four pages below traces back to one chemical fact: this compound class reacts irreversibly with cysteine, which explains its anti-inflammatory activity, its anticancer activity, its contact-allergy risk, and the open question over whether it helps or burdens the liver, all at once. The single most important finding across all four pages is not a positive one: the only controlled human trial ever run on this plant, for any indication — 10 healthy volunteers, a single dose each — found no effect at all.
Deep-Dive Articles
Deoxyelephantopin and the Cancer Research
The largest evidence base on this plant: deoxyelephantopin and related sesquiterpene lactones killing cancer cells across nasopharyngeal, lung, colorectal, cervical, liver, pancreatic, breast, bladder, brain, bone and kidney cell lines, plus real mouse tumor models and drug-chemosensitization findings for gemcitabine, tamoxifen, cisplatin and paclitaxel. Also: a 2026 finding that the same mechanism suppresses T-cell IL-2 production through the same pathway as transplant immunosuppressant drugs, and zero human trials of any kind.
Read the deep dive →Fever, Inflammation, and the Human Trial
The one page in this section built around a real human trial — a 1991–92 Brazilian placebo-controlled study that found no diuretic effect from this plant, and a companion rodent study whose antipyretic effect only appeared by injection, not by the oral route the tradition actually uses. Set against a separate, more recent cluster of positive Chinese and Taiwanese anti-inflammatory cell-culture findings, reported here as a genuine, unresolved contradiction rather than smoothed over.
Read the deep dive →Hepatoprotective Claims and the Glutathione Question
Real rodent evidence against four different liver toxins, from four independent labs — and a direct mechanistic tension with the same chemistry, since the compounds responsible for the plant's activity consume glutathione, the liver's principal detoxification reserve. Includes a 2013 liver-regeneration study that was formally retracted in 2017, named here so it is never mistaken for supporting evidence.
Read the deep dive →Antimicrobial Activity, Wound Healing, and Contact Allergy
Modest but real in-vitro antibacterial data, a wound-healing claim that traces to exactly one study of a two-plant combination rather than this herb alone, and a 2025 finding that this plant calms an atopic-dermatitis model in mice — set directly against the same compound class's well-established status as a standard contact-allergy patch-test allergen. Two real findings about the same molecules on the same organ, held together rather than picking one.
Read the deep dive →Table of Contents
Why One Reactive Bond Explains Nearly Everything Here
Deoxyelephantopin, isodeoxyelephantopin, scabertopin and the plant's other named sesquiterpene lactones all share an α-methylene-γ-butyrolactone group — a reactive double bond that acts as a Michael acceptor, binding irreversibly to the thiol group of cysteine, the most abundant soft nucleophile in a cell. That single property, described once, accounts for every major thread across the four pages below:
- The anticancer activity (detailed here) — alkylating a critical cysteine on IKKβ or the NF-κB p65 subunit shuts down a survival pathway many tumors depend on, while depleting glutathione raises oxidative stress preferentially in cells with less redox reserve to spare.
- The anti-inflammatory and antipyretic activity (detailed here) — the same NF-κB shutdown, in macrophages and microglia instead of tumor cells.
- The open question over liver protection versus liver burden (detailed here) — glutathione is synthesized and recycled chiefly in the liver, so a compound that consumes it is a plausible burden on hepatic detoxification capacity even as low, controlled exposure may precondition a protective Nrf2 antioxidant response.
- The contact-allergy risk (detailed here) — the same reactive group covalently binds skin proteins, which is the textbook definition of a hapten, the trigger for allergic sensitization.
- The immune-suppression finding (on the cancer page) — the same NF-κB and calcineurin/NFAT inhibition responsible for anticancer activity also suppresses T-cell IL-2 production, through a pathway shared with prescription transplant immunosuppressant drugs.
One mechanism, five consequences, three of them potential benefits and two of them potential hazards — and all five active at the same time in anyone who takes a concentrated preparation of this plant. A page that presents any one of the five without the others has understood only a fraction of the chemistry.
The Evidence Ledger
Not every claim on these four pages sits at the same evidence tier, and treating them as equivalent would flatten real distinctions. This ledger separates absent evidence (never adequately tested), old, weak and positive evidence (tested, but with real limitations worth naming), and the rare case of a genuine negative result (adequately tested and found not to work) — three different epistemic states, not one blur of "alternative medicine."
| Claim | Evidence Tier | Why |
|---|---|---|
| Diuretic effect (traditional) | Negative | A placebo-controlled comparison in 10 healthy volunteers, each given a single dose at five times the usual amount, found no diuretic, electrolyte or kidney-function effect — a small, single-dose test, yet still the only human evidence this plant has produced, in either direction. |
| Oral antipyretic effect | Negative (by the traditional route) | The only study to test oral administration specifically found no effect: in the 1992 rat study, both whole-plant extracts, “given intraperitoneally, ... reduced brewer's yeast-induced hyperthermia in rats, but when given orally did not affect it” — the effect appeared only when injected, a route nobody actually uses. |
| Anticancer activity (cell/mouse) | Real, preclinical only | Multi-laboratory, multi-cell-line, some real mouse tumor data. Zero human trials of any phase. |
| Anti-inflammatory activity (isolated compound/ethanol extract) | Real, preclinical only | Consistent, mechanistically coherent, multi-lab — but contradicted by the whole-aqueous-extract rodent data above (in the 1992 study both whole-plant extracts “failed to modify diuresis or carrageenan-induced rat paw edema”); see the solvent-substitution discussion. |
| Hepatoprotection (toxin-challenge models) | Old, weak and positive to real, preclinical | Four independent toxin models, consistent direction, but almost entirely pretreatment/prevention design, one key related paper retracted, and two supporting studies test a three-species mixture rather than this plant alone. |
| Antibacterial activity | Old, weak and positive | Real, quantified MIC data from a genuine hit in one screen, but modest potency and only three small studies across four decades. |
| Wound healing (specifically) | Absent for this plant alone | The one direct study tested a two-plant combination, not this herb in isolation. |
| Contact-allergy risk | Established (compound class) | Sesquiterpene lactone contact allergy is a standard, well-characterized clinical entity; this is the best human-relevant evidence connected to any claim on these four pages. |
| Acute toxicity | Route-dependent, rodent only | In the 1992 study, water and water-alcohol whole-plant extracts injected into the abdomen of mice (0.3–6 g/kg) caused writhing, loss of muscle tone, unsteadiness (ataxia), prostration and death (PubMed PMID: 1453704). A 2012 study reported that an ethanol extract given to mice by mouth showed no acute toxicity (PubMed PMID: 22973401). |
One of the four toxin models is alcohol. In mice given ethanol, an E. scaber ethanol extract at a low concentration reduced the rise in liver enzymes (aspartate aminotransferase, AST; alanine aminotransferase, ALT; alkaline phosphatase, ALP), triglycerides and bilirubin and the fat build-up in the liver; at a high concentration it reverted the liver damage to a level comparable to normal controls, as did the comparison herb Phyllanthus niruri (Ho and colleagues, 2012, PubMed PMID: 22973401).
Research Papers: Cancer
- Chen JJ, Yan QL, Bai M, et al. Deoxyelephantopin, a germacrane-type sesquiterpene lactone from Elephantopus scaber, induces mitochondrial apoptosis of hepatocarcinoma cells by targeting Hsp90α in vitro and in vivo (2023). Phytotherapy Research. — PubMed PMID: 36420857
- Cvetanova B, Li MY, Yang CC, et al. Sesquiterpene Lactone Deoxyelephantopin Isolated from Elephantopus scaber and Its Derivative DETD-35 Suppress BRAF(V600E) Mutant Melanoma Lung Metastasis in Mice (2021). International Journal of Molecular Sciences. — PubMed PMID: 33810045
- Ji D, Zhong X, Huang P, et al. Deoxyelephantopin induces apoptosis via oxidative stress and enhances gemcitabine sensitivity in vitro and in vivo through targeting the NF-κB signaling pathway in pancreatic cancer (2020). Aging. — PubMed PMID: 32526702
- Cai M, Qi R, Wang M, et al. Deoxyelephantopin, a natural sesquiterpene lactone, suppresses IL-2 production of ConA-activated T lymphocytes through inhibiting NF-κB and calcineurin/NFAT signaling (2026). European Journal of Pharmacology. — PubMed PMID: 42217719. The immune-suppression finding discussed above.
- Priyadarshni A, Sharma R, Bora KS, Dewangan HK. Pharmacological insights into deoxyelephantopin: a multifunctional sesquiterpene with therapeutic promise in cancer and neurodegenerative disorders (2026). Molecular Biology Reports. — PubMed PMID: 41961418
- Full citation list and cell-line-by-cell-line detail: see the Cancer Research page, which lists 13 papers individually.
Research Papers: Fever and Inflammation
- Laranja SM, Bergamaschi CM, Schor N. Evaluation of acute administration of natural products with potential diuretic effects, in humans (1991). Memorias do Instituto Oswaldo Cruz. — PubMed PMID: 1842009. The negative human trial.
- Laranja SM, Bergamaschi CM, Schor N. [Evaluation of three plants with potential diuretic effect] (1992; Portuguese, English abstract). Revista da Associação Médica Brasileira. — PubMed PMID: 1307052. The fuller report of the same 10-volunteer trial design.
- Poli A, Nicolau M, Simoes CM, Nicolau RM, Zanin M. Preliminary pharmacologic evaluation of crude whole plant extracts of Elephantopus scaber. Part I: In vivo studies (1992). Journal of Ethnopharmacology. — PubMed PMID: 1453704. The route-dependent antipyretic finding.
- Qi R, Li X, Zhang X, et al. Ethanol extract of Elephantopus scaber Linn. attenuates inflammatory response via the inhibition of NF-κB signaling by dampening p65-DNA binding activity in lipopolysaccharide-activated macrophages (2020). Journal of Ethnopharmacology. — PubMed PMID: 31877363
- Tsai CC, Lin CC. Anti-inflammatory effects of Taiwan folk medicine "Teng-Khia-U" on carrageenan- and adjuvant-induced paw edema in rats (1999). Journal of Ethnopharmacology. — PubMed PMID: 10075126. A three-species mixture; see the discussion on the inflammation page.
- Wang C, Sun D, Deng Q, et al. Elephantopus scaber L. Polysaccharides Alleviate Heat Stress-Induced Systemic Inflammation in Mice via Modulation of Characteristic Gut Microbiota and Metabolites (2024). Nutrients. — PubMed PMID: 38257155
- Full citation list and mechanism-by-mechanism detail: see the Fever and Inflammation page, which lists 12 papers individually.
Research Papers: Liver
- Rajesh MG, Latha MS. Hepatoprotection by Elephantopus scaber Linn. in CCl4-induced liver injury (2001). Indian Journal of Physiology and Pharmacology. — PubMed PMID: 11883157
- Lin CC, Yen MH, Chiu HF. The pharmacological and pathological studies on Taiwan folk medicine (VI): The effects of Elephantopus scaber subsp. oblanceolata, E. mollis and Pseudoelephantopus spicatus (1991). The American Journal of Chinese Medicine. — PubMed PMID: 1897489. The direct three-taxa comparison.
- Huang CC, Lin KJ, Cheng YW, et al. Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis (2013). The Journal of Nutritional Biochemistry. — PubMed PMID: 22748804
- Tsai CC, Wu JP, Lin YM, et al. The Effect of Elephantopus scaber L. on Liver Regeneration after Partial Hepatectomy (2013; retracted 2017). Evidence-Based Complementary and Alternative Medicine. — PubMed PMID: 23365606; retraction notice PubMed PMID: 29333183. Retracted; not evidence.
- Gao CS, Duan ZK, Lian MY, et al. Untargeted metabolomics and in-house database analysis reveal differences between Elephantopus scaber L. and Elephantopus tomentosus L. (2026). Journal of Chromatography A. — PubMed PMID: 41806488
- Ho WY, Yeap SK, Ho CL, et al. Hepatoprotective Activity of Elephantopus scaber on Alcohol-Induced Liver Damage in Mice (2012). Evidence-Based Complementary and Alternative Medicine. — PubMed PMID: 22973401
- Full citation list and the glutathione-mechanism discussion: see the Hepatoprotective Claims page, which lists 12 papers individually.
Research Papers: Antimicrobial and Skin
- Chen CP, Lin CC, Namba T. Screening of Taiwanese crude drugs for antibacterial activity against Streptococcus mutans (1989). Journal of Ethnopharmacology. — PubMed PMID: 2615434
- Aslam MS, Ahmad MS, Mamat AS, et al. Antioxidant and Wound Healing Activity of Polyherbal Fractions of Clinacanthus nutans and Elephantopus scaber (2016). Evidence-Based Complementary and Alternative Medicine. — PubMed PMID: 27528881. A combination study.
- Zang C, Cai M, Chen Q, et al. Elephantopus scaber attenuates MC903-caused atopic dermatitis and decreases TNF-α/IFN-γ-induced chemokines by suppressing MKP-1-mediated AP-1 signaling in keratinocytes (2025). Journal of Ethnopharmacology. — PubMed PMID: 40633861
- Sesquiterpene lactone mix and Compositae contact dermatitis (patch-test allergen literature). — Find on PubMed
- Full citation list and the computational-versus-laboratory distinction: see the Antimicrobial and Wound Healing page, which lists 10 papers individually.
External Authoritative Resources
- Dinh VH, Huynh TNN, Thuy TTT, et al. Elephantopus scaber L.: phytochemistry, pharmacology, nanoformulation, and synthetic modification – a review (2026). Natural Product Research. — PubMed PMID: 42160537 — the most current comprehensive scientific summary, cataloguing 131 secondary metabolites; its authors note that “challenges remain in bioavailability, pharmacokinetics, and comprehensive toxicity evaluation.”
- PubMed — All research on Elephantopus scaber
- PubMed — All research on deoxyelephantopin
- National Cancer Institute — Complementary and Alternative Medicine, for anyone weighing a plant-derived product alongside actual cancer treatment
Connections
- All Herbs
- Elephant's Foot (Main Page)
- Deoxyelephantopin and the Cancer Research
- Fever, Inflammation and the Human Trial
- Hepatoprotective Claims and the Glutathione Question
- Antimicrobial Activity, Wound Healing and Contact Allergy
- Andrographis
- Chrysanthemum
- Feverfew
- Turmeric
- Milk Thistle
- Glutathione
- Oncology
- Liver Disease
- Contact Dermatitis